Lyka Labs Ltd share price logo

Lyka Labs Share Price

NSE: LYKALABS

BSE: 500259

Small Cap

Healthcare Sector

₹75.46

+1.02

(+1.37%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Lyka Labs Stock Performance

as on December 19, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹74.37
    ₹76
    downward going graph

    1.44%

    Downside

    0.72%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹72.2
    ₹167.19
    downward going graph

    4.32%

    Downside

    121.56%

    Upside

    downward going graph

Lyka Labs share price movements today

Previous Close
₹74.44
Open
₹75.40
Volume
9,496.00
Upper Circuit
₹89.32
Lower Circuit
₹59.56
Day's Low - High
₹74.37 - ₹76
52 Week Low - High
₹72.2 - ₹167.19

Lyka Labs Historical Returns

1 Month Return
-5.89 %
3 Month Return
-24.26 %
1 Year Return
-49.61 %
3 Year Return
-41.95 %
5 Year Return
+ 265.42 %

Lyka Labs Fundamentals

as on December 19, 2025 at 4:01 pm IST

Market Cap

₹269.32 Cr

Return on Equity (ROE)

4.99

PE Ratio (TTM)

137.2

Return on capital employed (ROCE)

6.37

Industry PE ratio

41.58

Beta (LTM)

0.93

P/B Ratio

2.67

Dividend Yield

0

PEG Ratio

47.8

Quarterly Earnings Growth YOY

-268.06

EPS (TTM)

2.22

Sector

Pharmaceuticals

Book Value

29.01

Technical Analysis

Bearish

View Technical Analysis

Lyka Labs Stock Valuation

as on December 19, 2025 at 4:01 pm IST

Lyka Labs in the last 5 years

  • Overview

  • Trends

Lowest (-164.66x)

September 10, 2018

Industry (41.58x)

December 19, 2025

Today (137.20x)

December 19, 2025

Highest (178.85x)

October 13, 2025

LowHigh

Today’s Price to Earnings Ratio: 137.20x

Lyka Labs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lyka Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Lyka Labs Ltd image
Lyka Labs Ltd
NA269.3253.08%0.647138
Amrutanjan Health Care Ltd image
Amrutanjan Health Care Ltd
NA1,977.348.41%0.00NANA
Jenburkt Pharmaceuticals Ltd image
Jenburkt Pharmaceuticals Ltd
NA480.9031.61%0.0032151
Amwill Health Care Ltd image
Amwill Health Care Ltd
NA79.57-11.47%0.001040
Beta Drugs Ltd image
Beta Drugs Ltd
NA1,544.47270.52%0.7142362
See all

Lyka Labs Stock’s Investor Sentiment and Interest

Search interest for Lyka Labs Ltd Stock has increased by 203% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:203% versus previous 30 day period

Lyka Labs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
17.82
22.24
22.88
27.99
32.56
27.77
30.11
41.16
33.8
33.43
33.03
36.66
Other Income
1.06
0.43
0.38
0.25
0.54
0.32
0.56
0.03
0.83
0.82
0.63
1.09
Total Income
18.88
22.67
23.25
28.23
33.11
28.08
30.67
41.18
34.62
34.25
33.66
37.75
Expenses
22.61
19.35
20.23
24.24
25.7
25.74
26.41
36.2
28.6
29.35
29.34
39.2
Operating Profit
-4.79
2.89
2.65
3.75
6.86
2.03
3.7
4.96
5.2
4.08
3.69
-2.54
Operating Profit Margin %
-26.88%
12.99%
11.58%
13.4%
21.07%
7.31%
12.29%
12.05%
15.38%
12.2%
11.17%
-6.93%
Profit Before Interest, Tax and Depreciation
-3.73
3.31
3.02
3.99
7.41
2.34
4.27
4.98
6.02
4.9
4.32
-1.45
Interest
3.08
2.85
1.35
1.19
1.28
1.07
0.65
0.54
0.61
0.47
0.85
0.79
Depreciation
3.47
3.47
3.47
3.59
2.84
2.9
1.76
1.76
1.83
1.42
2.11
2.15
Profit Before Tax
-10.28
-3.01
-1.8
-0.79
3.29
-1.63
1.86
2.68
3.58
3.01
1.36
-4.39
Tax Paid
0.23
-
0.13
-0.18
1.27
0.46
0.57
0.76
0.87
0.99
0.36
-1.17
Profit After Tax
-10.42
-3.01
-1.85
-0.49
1.78
-2.09
1.29
1.91
2.7
2.03
1
-3.21
Total Net profit including share of profit / Loss from associate company
-10.42
-3.01
-1.85
-0.49
1.78
-2.09
1.29
1.91
2.7
2.03
1
-3.21
EPS
-3.64
-1.05
-0.57
-0.15
0.53
-3.83
0.4
0.58
0.75
0.49
0.25
-0.94
Actual EPS
-3.64
-1.05
-0.57
-0.15
0.53
-3.83
0.4
0.58
0.75
0.49
0.25
-0.94
Adjusted EPS
-3.64
-1.05
-0.57
-0.15
0.53
-3.83
0.4
0.58
0.75
0.49
0.25
-0.94
Diluted EPS
-3.64
-1.05
-0.57
-0.15
0.53
-3.83
0.4
0.58
0.75
0.49
0.25
-0.94

Lyka Labs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
110.08
59.81
70.78
61.49
86.25
194.08
93.07
111.19
138.5
Other Income
2.24
6.16
2.09
3.09
1.56
2.09
3.4
1.45
2.23
Total Income
112.32
65.96
72.87
64.58
87.81
196.18
96.47
112.65
140.73
Expenses
91.45
63.36
73.81
98.38
67.7
99.45
83.63
95.89
120.56
Operating Profit
18.63
-3.55
-3.03
-36.89
18.55
94.63
9.44
15.3
17.94
Operating Profit Margin %
16.92%
-5.94%
-4.28%
-59.99%
21.51%
48.76%
10.14%
13.76%
12.95%
Profit Before Interest, Tax and Depreciation
20.87
2.61
-0.94
-33.8
20.12
96.73
12.85
16.76
20.17
Interest
18.72
9.58
7.17
20.07
25.94
20.13
11.87
4.89
2.27
Depreciation
10.25
11.28
7.31
8.01
8.32
17.35
14.15
12.8
6.77
Profit Before Tax
-8.1
-18.25
-15.42
-61.88
-14.14
59.25
-13.17
-0.93
11.13
Tax Paid
-1.51
-1.04
-9.07
0.74
-4.05
20.8
-0.02
1.69
3.2
Profit After Tax
-5.55
-17.22
-5.61
-60.54
-11.55
39
-13.21
-2.62
7.93
Total Net profit including share of profit / Loss from associate company
-5.55
-17.22
-5.61
-60.54
-11.55
39
-13.21
-2.62
7.93
EPS
-2.57
-6.71
-1.79
-21.29
-4.07
13.57
-4.63
-0.79
2.22
Actual EPS
-2.57
-6.71
-1.79
-21.29
-4.07
13.57
-4.63
-0.79
2.22
Adjusted EPS
-2.57
-6.71
-1.79
-21.29
-4.07
13.57
-4.63
-0.79
2.22
Diluted EPS
-2.57
-6.71
-1.79
-21.29
-4.07
13.57
-4.63
-0.79
2.22

Lyka Labs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
11.95
31.38
10.88
26.67
5.32
8.81
79.25
8.95
1.77
1.9
Cash Flow from Investing Activities
17.29
-12.67
-3.17
-3.97
-0.11
-0.16
-6.17
7.35
-9.49
-11.79
Cash Flow from Financing Activities
-28.82
-19.15
-10.41
-23.43
3.39
-11.81
-63.18
-21.64
1.95
5.29
Net Cash Flow
-0.96
-0.43
-2.69
-0.72
8.6
-3.15
9.9
-5.34
-5.76
-4.6

Lyka Labs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Apr 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
51%
54.56%
54.58%
54.81%
54.81%
54.81%
58.1%
58.1%
58.1%
58.1%
58.16%
58.16%
58.16%
DII
3.74%
3.09%
0.41%
0.41%
0.41%
0.88%
0.82%
0.75%
0.67%
0.67%
0.67%
0.67%
0.67%
FII
0%
0%
0%
0.18%
0%
0.17%
0.16%
0.15%
0.15%
0.15%
0.23%
0.16%
0.18%
Public
45.08%
42.19%
44.85%
44.6%
44.4%
44.13%
40.92%
40.99%
41.08%
41.08%
40.94%
41.01%
41%
Total Outstanding Shares
3,06,90,000
3,30,90,000
3,30,90,000
3,30,90,000
3,30,90,000
3,30,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
Total Shareholders
26,820
26,870
27,202
26,652
26,422
25,717
25,699
25,716
28,943
29,099
28,472
28,189
27,743

Lyka Labs Corporate Actions

View detailed summary of the earnings and dividend history of Lyka Labs.

  • Lyka Labs Ltd Earnings Results

    Lyka Labs Ltd’s net profit fell -260% since last year same period to ₹-3.36Cr in the Q2 2025-2026. On a quarterly growth basis, Lyka Labs Ltd has generated -461.29% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Lyka Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.16% to 0.17% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 33.66 Cr → 37.75 Cr (in ₹), with an average increase of 10.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 141.3% return, outperforming this stock by 183.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 58.16% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 10.8% return, outperforming this stock by 60.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, LYKALABS stock has moved down by -33.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 2.7 Cr → -3.36 Cr (in ₹), with an average decrease of 181.1% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 41.01% to 41.00% in Sep 2025 quarter

About Lyka Labs Ltd

Lyka Labs, a bulk drug company, has been in the business of offering lifesaving antibiotics and treating minor infections for over three decades. Over the years, the company has also diversified into marketing medical and diagnostic machinery and equipment, ayurvedic and animal health care products, tropical steroids, anticancer products, cardiovascular drugs, and anti-inflammatory products. In the year 1991 they received a Certificate of Merit for their impressive export performance and an award from CHEMEXCIL. Two years later, their Administrative Office and Plant at Tarapur was awarded the ISO 9002 certification for its quality management system. As part of its diversification, the company had also invested in Relic Finance and acquired 26.70% of the company's paid-up equity capital through a public offer. They also launched India's first Glutathione Injection formulation during 2012-13 to become one of India's leading healthcare and pharmaceutical companies.

Revenue: ₹36.66Cr as on September 2025 (Q2 FY26)
Net Profit: ₹-3.21Cr as on September 2025 (Q2 FY26)
Listing date: 08 Feb, 1995
Chairperson Name: KUNAL NARENDRA GANDHI
OrganisationLyka Labs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOKUNAL NARENDRA GANDHI
E-voting on sharesClick here to vote

FAQs

What is Lyka Labs share price today?

Lyka Labs share price today stands at ₹75.46 as on at the close of the market. Lyka Labs share today touched a day high of ₹76 and a low of ₹74.37.

What is the 52 week high and 52 week low range for Lyka Labs share?

Lyka Labs touched a 52 week high of ₹167.19 and a 52 week low of ₹72.2. Lyka Labs share price today i.e. is closed at ₹75.46, which is -54.87% down from its 52 week high and 4.52% up from its 52 week low.

What is Lyka Labs's market capitalisation today?

Lyka Labs market capitalisation is ₹269.32 Cr as on .

How to buy Lyka Labs shares?

To buy Lyka Labs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LYKALABS or Lyka Labs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Lyka Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Lyka Labs trading volume today?

Lyka Labs trading volume is 9,496.00 as on . This means that 9,496.00 shares of Lyka Labs were bought and sold on the stock market during today's trading session.